Glutamate excitotoxicity is caused by sustained activation of neuronal NMDA receptors causing a large Ca 2ϩ and Na ϩ influx, activation of poly(ADP ribose) polymerase-1 (PARP-1), and delayed Ca 2ϩ deregulation. Mitochondria undergo early changes in membrane potential during excitotoxicity, but their precise role in these events is still controversial. Using primary cortical neurons derived from mice, we show that NMDA exposure results in a rapid fall in mitochondrial ATP in neurons deficient in SCaMC-3/Slc25a23, a Ca 2ϩ -regulated mitochondrial ATP-Mg/Pi carrier. This fall is associated with blunted increases in respiration and a delayed decrease in cytosolic ATP levels, which are prevented by PARP-1 inhibitors or by SCaMC-3 activity promoting adenine nucleotide uptake into mitochondria. SCaMC-3 KO neurons show an earlier delayed Ca 2ϩ deregulation, and SCaMC-3-deficient mitochondria incubated with ADP or ATP-Mg had reduced Ca 2ϩ retention capacity, suggesting a failure to maintain matrix adenine nucleotides as a cause for premature delayed Ca 2ϩ deregulation. SCaMC-3 KO neurons have higher vulnerability to in vitro excitotoxicity, and SCaMC-3 KO mice are more susceptible to kainate-induced seizures, showing that early PARP-1-dependent fall in mitochondrial ATP levels, counteracted by SCaMC-3, is an early step in the excitotoxic cascade.
Introduction
Glutamate (Glu) is the main excitatory neurotransmitter of the CNS, but at micromolar concentrations it triggers neuronal death through persistent activation of NMDA receptors (Tymianski et al., 1993; Budd and Nicholls, 1996; Nicholls, 2008) .
Mitochondrial Ca 2ϩ plays a key role in glutamate excitotoxicity and preventing Ca 2ϩ uptake by mitochondria protects against neuronal death (Stout et al., 1998; Qiu et al., 2013 ). Another important player is poly(ADP ribose) polymerase-1 (PARP-1), activated by DNA strand breaks, which uses NAD ϩ to produce ADP-ribose polymers bound to proteins (Andrabi et al., 2006) . Glutamate excitotoxicity causes the production of reactive oxygen species (ROS) and reactive nitrogen species (BrennanMinnella et al., 2013) , which damage DNA and activate PARP-1, and neurons treated with PARP-1 inhibitors (Abramov and Duchen, 2008; Duchen, 2012) and PARP-1 KO mice are remarkably resistant to glutamate/NMDA excitotoxicity (Eliasson et al., 1997; Mandir et al., 2000) .
The detrimental role of PARP-1 activation in excitotoxicity has been attributed to the PAR polymer (Andrabi et al., 2006) , whose formation depletes cytosolic NAD ϩ , which would lead to an impairment of the NAD ϩ -dependent steps of glycolysis (Alano et al., 2010) or to a reduction of cytosolic ATP as a result of ATP use in the resynthesis of NAD ϩ . However, little is known of the effects of PARP-1 activation on mitochondrial NAD ϩ and ATP levels, particularly within the time window of the immediate response to glutamate/NMDA. SCaMCs/APCs are mitochondrial ATP-Mg/Pi carriers (Aprille, 1993; Fiermonte et al., 2004; del Arco and Satrú stegui, 2004) involved in Ca 2ϩ stimulation of mitochondrial respiration in liver and in increasing the Ca 2ϩ retention capacity (CRC) of mitochondria in cancer cells (Traba et al., 2012; Amigo et al., 2013 , resulting in changes in the total adenine nucleotide (AdN) concentration (ATP plus ADP plus AMP) in the mitochondrial matrix (Nosek et al., 1990) . SCaMC-3/APC2/Slc25a23 expressed in liver and brain, and it is activated to half maximal levels at ϳ3.3 M Ca .
The aim of the present study was to investigate the relevance of SCaMC-3 in the function of brain mitochondria and intact neurons during the early response to glutamate or NMDA through the use of SCaMC-3 KO mice , particularly in the early NMDA-induced activation of respiration (Jekabsons and Nicholls, 2004; Gleichmann et al., 2009) , and its impact on the delayed responses to these agonists both in vitro and in vivo. The results reveal that NMDA-induced PARP-1 activation results in a rapid drop in mitochondrial ATP levels, which is unmasked by SCaMC-3 deficiency. This drop is prevented by SCaMC-3 activity transporting AdNs into neuronal mitochondria immediately after NMDA exposure. In addition to this early effect, the increase in matrix AdNs brought about by SCaMC-3 confers a higher Ca 2ϩ retention capacity to mitochondria, delays Ca 2ϩ deregulation in neurons exposed to glutamate, and results in protection by SCaMC-3 against glutamate excitotoxicity in vitro and in vivo.
Materials and Methods
Animals. SCaMC-3-deficient mice were generated by Lexicon with a mixed C57BL/6Sv129 genetic background. Animals are born in Mendelian proportions and show no evident phenotypic traits. Genotyping was performed as previously described . Animals were killed by cervical dislocation. All animal work performed in this study was performed in accordance with procedures approved in Directive 86/609/EEC of the European Union and with approval of the Ethics Committee of the Universidad Autó noma de Madrid.
Cortical neuron cultures and glutamate treatment.
Cultures were prepared as described previously . Cells were seeded at a density of 1 ϫ 10 5 cells/cm 2 on poly-L-lysine and laminin (1 g/ml)-coated plates, unless otherwise indicated. Glu and NMDA treatments were performed in neuronal cultures at 8 -10 d in vitro (DIV) to allow the expression of glutamate receptors in neurons. Medium was replaced with 600 l of MEM supplemented with the indicated NMDA/Glu concentration, making duplicates or triplicates of every concentration. After 5 min, MEM was replaced with Neurobasal medium supplemented with B-27, GlutaMAX, and antibiotics (NBc). In experiments using PARP-1 inhibitors, these were present during preincubation, glutamate/NMDA exposure, and the recovery period in NBc. Viability assays were performed 6 -24 h later with the calcein-AM versus propidium iodide method. Neuron cultures were incubated 15 min with 1 M calcein-2 M propidium iodide (PI) in the dark, and images (five per condition) were then obtained with an Axiovert 200 epifluorescence microscope (Zeiss) coupled to a monochrome-color CCD camera using a 10ϫ dry objective in red and green channels. Red (PI positive) and green (calcein positive) cells were counted in 11 fields per treatment, and genotypes and a live/total cells percentage were generated and compared between genotypes.
Imaging of cytosolic-mitochondrial Ca 2ϩ and ATP in primary neuronal cultures. Single-cell measurements of cytosolic and mitochondrial Ca 2ϩ were performed as described previously (Llorente-Folch et al., 2013) using neurons loaded with Fura-2, or neurons transfected using Effectene (Qiagen) 24 h prior to the experiments either with the plasmid coding for mitochondrially targeted ratiometric GEM-GECO-1 (plasmid 32461, Addgene; or with the plasmid coding for either Cyt GO-ATeam 1 or Mit GO-ATeam 2 (provided by H. Noji) and processed as previously described . Experiments were performed in HEPES-control salt solution (HCSS) containing 2.5 mM glucose either with 2 mM CaCl 2 or 100 M EGTA. When used, PARP-1 inhibitors were preincubated (24 h for PJ-34 and DPQ, and 10 min for 3-AB) and maintained throughout the experiment. Briefly, cells were excited for 100 ms at 436/20 nm for Mit-GEM-GECO1, at 485/27 nm for GO-ATeam and alternatively at 426/44 (Venus) and 472/499 (GFP) for Perceval HR measurements. The emitted fluorescence was collected through a dual-pass dichroic CFP-YFP (440/500 nm and 510/600 nm) alternatively at 480/40 nm (CFP) and 535/30 nm (YFP) for Mit-GEM-GECO-1, through a FF495-Di03 dichroic at 520/35 nm (GFP) and 567/15 nm (OFP) for GO-ATeam, and at 520/35 nm (GFP) for Perceval HR probe. Images were collected every 5 s. using a filter wheel (Lambda 10-2, Sutter Instruments; all filters purchased from Chroma) and recorded by a Hamamatsu C9100-02 camera mounted on an Axiovert 200M inverted microscope equipped with a 40X/1.3 Plan-Neofluar objective. The Mit-GEM-GECO1 emission ratio was CFP/YFP, while the GO-ATeam emission ratio was OFP/GFP, reflecting mitochondrial Ca 2ϩ and ATP levels respectively. For Mit-GEM GECO1 imaging, ROIs were selected on mitochondrial-containing areas (identified based on their morphology). Single-cell fluorescence recordings were analyzed using ImageJ (NIH) or MetaMorph (Universal Imaging), and data analysis was performed with Origin software (Originlab). For rescue experiments, the whole full-length cDNA sequence of SCaMC-3 was cloned into the pCAGGS expression vector under the control of the ␤-globin promoter. pCAGGS-SCaMC-3 and Mit GO-ATeam 2 were cotransfected, and experiments were performed 24 h later. SCaMC-3 expression levels were assessed by immunofluorescence using a monoclonal antibody against full-length SCaMC-3, which was produced in our laboratory (1:100).
Mitochondrial and cytosolic reactive oxygen species formation. Neurons were seeded in 96-well plates at a density of 300,000 cells/cm 2 , and at 8 -10 DIV were loaded with either 1 M dihydroethidium, keeping the dye present throughout measurements of cytosolic ROS; or with 3 M MitoSOX for 10 min; washed; and used to monitor mitochondrial ROS (Robinson et al., 2008) . Loading and recordings were made in HCSS plus 2 mM CaCl 2 . Hydroxyethidium and oxidized MitoSOX fluorescence was evaluated in a FLUOstar OPTIMA fluorescence plate reader using an excitation 530-10 filter and emission 620-10 BP filter, and NMDA additions were made using a fluidic controller. In addition, neurons were loaded and visualized under the microscope stage to ensure proper cytosolic and mitochondrial localization of the dyes in these loading conditions. Data analysis was performed with Origin software (Originlab).
Immunohistochemistry. Free-floating brain sections from kainic acid (KA)-treated mice were washed in PBS and blocked in PBS-1% horse serum-0.25% Triton X-100 for 1 h before incubating overnight with the primary antibody (1:200; GFAP, Dako) in the same medium at 4°C. The excess of antibody was washed three times in PBS, and a secondary fluorescent antibody (1:250; Alexa Fluor 488 anti-rabbit, Invitrogen) was then incubated for 1 h. Secondary antibody was washed three times in PBS, and sections were mounted in polylysine-coated glass slides (Menzel-Glässer) using mowiol. Immunoreactivity was quantified using images of three different coronal sections of the hippocampus, corresponding approximately to positions 261, 281, and 301 from the Allen Brain Mouse Atlas, which were taken at 10ϫ magnification with an Axioskop 2 Plus vertical microscope (Zeiss) coupled to a Coolsnap FX CCD camera (Roper Scientific) using the same settings for all the samples. GFAP fluorescence was quantified using ImageJ software. A region of interest including CA1, CA2, CA3, and the dentate gyrus was delimited, and its total area was calculated. The total area occupied by GFAP fluorescence was quantified by manually introducing a threshold that was maintained throughout the analysis of all images. Measures were performed in a blind manner and expressed as the percentage of the GFAP fluorescent area with respect to the total area (Zamanian et al., 2012) .
Measurement of cellular oxygen consumption. The oxygen consumption rate (OCR) was measured using a Seahorse XF24 Extracellular Flux Analyzer (Seahorse Bioscience; Qian and Van Houten, 2010). Cortical pri-mary neurons were plated at 1.5 ϫ 10 5 cells/well in XF24 V7 plates and incubated at 37°C in 5% CO 2 in the conventional serum-free B27-supplemented Neurobasal medium with 30 mM glucose (Brewer et al., 1993) . Cells were equilibrated with bicarbonate-free DMEM (without pyruvate, lactate, glucose, glutamine, and Ca 2ϩ ) supplemented with 2.5 mM glucose and 2 mM CaCl 2 or 100 M EGTA for conditions of plus or minus Ca 2ϩ , for 1 h immediately before the assay. When used, PARP-1 inhibitors were preincubated (24 h for PJ-34 and DPQ, and 10 min for 3-AB) and maintained throughout the experiment. After a baseline measurement, neurons were stimulated with NMDA, and mitochondrial function was determined as described previously (Llorente-Folch et al., 2013) . It should be noted that the differential response to 25, 50, and 100 M NMDA is only observed within a small time window in cultured neurons, as neuronal maturation and the response to NMDA are exquisitely sensitive to the age of the culture (Abramov and Duchen, 2010; Guo et al., 2013) .
Swelling and Ca 2ϩ uptake in isolated mitochondria. Liver and brain mitochondria were isolated as previously described (Contreras and Satrú stegui, 2009 ) and resuspended in MSK buffer (75 mM D-mannitol, 25 mM sucrose, 5 mM KH 2 PO 3 , 20 mM Tris-HCl, 0.5 mM EDTA, 100 mM KCl, and 0.1% BSA free of fatty acids, pH 7.4). All experiments were performed in MSK devoid of EDTA at 30°C in the presence of 1 mM MgCl 2 and respiratory substrates (5 mM succinate plus 2 M rotenone), and in the presence or absence of AdNs (ATP or ADP). Mitochondrial swelling in liver mitochondria was measured by monitoring the decrease in absorbance of the suspension at 540 nm, reflecting decreased light scattering, as previously described (Amigo et al., 2012) , using a Nicolet Evolution 300 spectrophotometer (Thermo Scientific) provided with temperature control and continuous stirring. Swelling was monitored through sequential additions of 200 -1000 nmol CaCl 2 . Forty micrograms of alamethicin was added at the end of the assays as a control for maximal swelling. The CRC of isolated brain mitochondria was measured with the Ca 2ϩ -sensitive fluorescent probe Calcium-Green 5N (0.1 M; excitation, 506 nm; emission, 532 nm) as previously described (Traba et al., 2012) , using an AMINCO-Bowman fluorimeter provided with continuous stirring and temperature control. One hundred micromolar digitonin was added to the buffer. After 3-5 min of incubation, mitochondria were challenged with subsequent 10 -20 nmol CaCl 2 additions, as indicated in the figure legends, and Ca 2ϩ uptake into mitochondria was measured from the decrease in external Ca 2ϩ reflected in decreased calcium-green fluorescence.
Kainic acid treatment. KA (25 mg/kg; Sigma-Aldrich) was administrated intraperitoneally to 3-month-old male wild-type (WT) and SCaMC-3 KO mice (n ϭ 8 mice for each genotype). In each experiment, wild-type and SCaMC-3 KO mice from the same litter were visually monitored in parallel for 2 h, and seizure severity was quantified in a blind manner using the following classification (McLin et al., 2006) : (1) unmoving and crouched in a corner, staring; (2) body stretched out, tail becomes straight and rigid, ears laid back, with bulging eyes; (3) repetitive head bobbing, rears into a sitting position; (4) rearing and falling, tonic clonic seizures broken by periods of total stillness, jumping clonus, running clonus; (5) continuous level 4 seizures; (6) body in clonus, no longer using limbs to maintain posture, usually precursor to death; and (7) death. For data analysis, the most severe state every 5 min was used. Mice were killed 7 d after drug administration, and brain sections extracted for histological analysis as described above.
Electrophysiology. Whole-cell current-clamp recordings were obtained from in vitro cultured neurons at 8 -9 DIV. Patch pipettes (3-6 M⍀) were filled with an intracellular solution containing 115 mM K-gluconate, 20 mM KCl, 2 mM MgCl 2 , 10 mM HEPES, 4 mM ATP ⅐ 2Na, and 0.3 mM GTP ⅐ 3Na, adjusted to pH 7.2 with KOH, and to 290 mOsm with KCl. During recording, neurons were perfused with artificial CSF containing 119 mM NaCl, 2.5 mM KCl, 1 mM NaH 2 PO 4 , 11 mM glucose, 26 mM NaHCO 3 , 1.3 mM MgCl 2 , and 2.5 mM CaCl 2 , and gassed with 95% O 2 , 5% CO 2 . Current-clamp whole-cell recordings were obtained with a Multiclamp 700A amplifier (Molecular Devices). All properties were analyzed using pCLAMP Clampfit version 10.3 (Molecular Devices). Excitability was quantified as the number of action potentials (APs) evoked by a series of depolarizing current steps (0 -400 pA, 350 ms). Resting membrane potential, threshold for action potential firing, and input resistance were obtained from the same traces.
Statistical analysis. In all cases, data are presented as the mean Ϯ SEM. The number of independent experiments is indicated in the figure legend in each case. Statistical significance was determined using a two-tailed unpaired Student's t test, unless otherwise indicated.
Results
The early stimulation of respiration in response to NMDA is highly Ca 2؉ sensitive and is larger in WT than in SCaMC-3 KO neurons Ca 2ϩ -dependent AdN uptake through the ATP-Mg/Pi carrier increases respiration in AdN-depleted mitochondria (Nosek et al., 1990; Amigo et al., 2013) , and is responsible for the acute increase in matrix AdN content and coupled respiration caused by glucagon in the liver (Aprille et al., 1982; Amigo et al., 2013) . Neurons have a large capacity to increase mitochondrial coupled respiration in response to high workloads, which depends on Ca 2ϩ activation of respiration, rather than on Ca 2ϩ -induced ATP utilization (Llorente-Folch et al., 2013) .
To test the effects of SCaMC-3 in this context, we studied the role of SCaMC-3 in respiration of intact neurons during an increase in workload caused by exposure to NMDA. NMDA causes Na ϩ and Ca 2ϩ entry through ionotropic NMDA receptors and voltage-gated Ca 2ϩ channels in cortical neurons. The absence of Ca 2ϩ , which prevents the increase in [Ca 2ϩ ] i (Fig. 1B ) causes a larger increase in Na ϩ (Fig. 1A) , possibly because of competition between Na ϩ and Ca 2ϩ , as both cations are permeable through NMDA receptors (Mayer and Westbrook, 1987) . Most of the workload caused by the entry of these cations is due to Na ϩ entry rather than Ca 2ϩ entry, which triggers Na ϩ efflux on the Na However, NMDA induced an increase in OCR that was much larger in the presence of than in the absence of Ca 2ϩ (Fig. 1C,D) , even when the Na ϩ -dependent workload is higher in Ca 2ϩ -free medium. This suggests that the lack of Ca 2ϩ regulation of mitochondrial respiration limits NMDA-induced stimulation of respiration in a Ca 2ϩ -free medium. In fact, cytosolic ATP imaging with the low-affinity ATP probe Cyt GO-ATeam 1 (K d ϭ 7.1 mM), which is not affected by physiological pH changes , showed that NMDA promotes a much larger depletion of cytosolic ATP in the absence of Ca 2ϩ than in its presence (Fig. 1E ). This indicates that during NMDA exposure in Ca 2ϩ -free medium, failure to upregulate mitochondrial respiration in response to Ca 2ϩ causes a progressive fall in cytosolic ATP. NMDA-induced early mitochondrial depolarization, shown as a decrease in tetramethylrhodamine methyl ester (TMRM) fluorescence (Davidson et al., 2007) , was partially prevented in the absence of Ca 2ϩ ( Fig. 1F ) , and completely prevented in the presence of oligomycin (Fig. 1G) . Moreover, when NMDA was added in the presence of Ca 2ϩ and oligomycin, an increase in TMRM fluorescence was observed (Fig. 1G ), indicating mitochondrial hyperpolarization consistent with NMDA-induced Ca 2ϩ stimulation of mitochondrial energization that is unmasked when ATP synthesis is prevented by oligomycin.
SCaMC-3 is widely expressed in brain, and is present in primary cortical neurons and, at lower levels, in glial cultures. Brain mitochondria from SCaMC-3 KO mice do not show changes in respiration with complex I and II substrates, in cytochrome oxidase activity, or in the content of adenine nucleotides (results not shown). We investigated early respiratory responses to NMDA in WT and SCaMC-3 KO neurons both in the presence and absence of Ca 2ϩ ( Fig. 2A-C) . Neurons from both genotypes showed a similar OCR response to NMDA in Ca 2ϩ -free medium, while the increased response in the presence of Ca 2ϩ that is characteristic of WT neurons was severely reduced in KO neurons (Fig. 2C) , although the initial increase in [Ca 2ϩ ] i was the same in neurons from both genotypes (Fig. 2D) . Figure 2E -G shows that in Ca 2ϩ -free medium, NMDA caused a similar drop in cytosolic ATP in WT and SCaMC-3 KO neurons; however, in the presence of Ca 2ϩ , ATP depletion was larger in KO neurons than in WT neurons . This was confirmed using the ATP-to-ADP sensor Perceval HR (Tantama et al., 2013) , which showed a larger fall in the ATP/ADP ratio after NMDA exposure in SCaMC-3 KO neurons than in WT neurons ( Fig. 2H-J) . These results suggest that failuretoupregulaterespirationinresponsetoNMDAinthepresenceof Ca 2ϩ caused the larger fall in cytosolic ATP/ADP ratio in KO neurons.
We next determined matrix-free Ca 2ϩ levels in SCaMC-3-deficient neurons exposed to NMDA with the mitochondrially [Ca 2ϩ ] cyt , in Fura-2 loaded neurons (ϳ60 neurons per condition and 2 independent platings). C, D, NMDA-induced stimulation of OCR as a percentage of basal values (n ϭ 7-9 experiments). E, [ATP] cyt in neurons transfected with cyt-GO-ATeam1; results were expressed as R/Ro for normalization to prestimulation values (Ro); results were normalized to prestimulation values and correspond to 30 -50 neurons per condition and independent platings. The drop of ATP values with respect to basal levels 300 s after NMDA addition was 34.85 Ϯ 2.7% in the presence of Ca 2ϩ and 48.60 Ϯ 3.1% in the absence of Ca 2ϩ . F, G, Neurons were loaded with 5 nM TMRM (nonquench mode), and were allowed to equilibrate for 30 min before NMDA addition (F ) or after a pretreatment with 6 M oligomycin (Oli) before NMDA addition (G). Results (mean Ϯ SEM) were normalized to prestimulation values. Dinitrophenol (DNP) and antimycin/rotenone (A/R; 1 M/1 M) were added at the end of experiments to ensure complete mitochondrial depolarization. *p Յ 0.05; ***p Յ 0.001, two-tailed unpaired Student's t test. targeted, ratiometric GEM-GECO1 . In response to NMDA, there was an initial steep increase in Mit-GEM/ GECO1 ratio ([Ca 2ϩ ] mit ) followed by a secondary rise (Fig. 2K-N ) , similar to those reported in response to lower (10 -20 M) NMDA doses with other protein-based Ca 2ϩ sensors expressed in neuronal mitochondria (Qiu et al., 2013) . The initial increase was greater in SCaMC-3 KO neurons than in WT neurons, and SCaMC-3-deficient neurons also maintained a higher [Ca 2ϩ ] mit level throughout the duration of the recordings (Fig. 2M ) , thus ruling out impaired signaling to mitochondria via the Ca 2ϩ uniporter as a cause of the blunted NMDA stimulation of OCR in SCaMC-3 KO neurons. NMDA-induced depolarization was similar in WT and KO neurons (results not shown), excluding differences in mitochondrial depolarization as the cause of the reduced OCR stimulation.
NMDA exposure causes a rapid drop in mitochondrial ATP, which is prevented by AdN uptake through SCaMC-3 Having found that the deficient respiratory response to NMDA in SCaMC-3 KO neurons is not caused by a lower ATP demand but reflects a failure to upregulate respiration in the presence of Ca 2ϩ , we next studied mitochondrial ATP levels after NMDA exposure both in the presence and in the absence of Ca 2ϩ . To this end, we used the high-affinity ATP probe Mit GO-ATeam 2 (K d ϭ 2.3 mM; Nakano et al., 2011) and imaged mitochondrial ATP changes caused by NMDA [ Fig. 3A -D (images from a representative experiment in D)]. In the presence of 2 mM CaCl 2 , NMDA was found to promote a delayed drop in mitochondrial ATP levels in control neurons (Fig. 3 A, D) . Strikingly, SCaMC-3 KO neurons showed an immediate steep fall in [ATP] mit . Differences among genotypes disappeared in Ca 2ϩ -free medium (Fig. 3B ). The expression of SCaMC-3 in the KO neurons with pCAGGSSCaMC-3 resulted in prevention of the fall in mitochondrial ATP caused by NMDA (Fig. 3 E, F ). Under these conditions, SCaMC-3 protein levels were restored, as verified by immunofluorescence (Fig. 3G) . These results suggest an important role of SCaMC-3 in the maintenance of ATP homeostasis in the early response to NMDA exposure. In the absence of SCaMC-3, NMDA causes an immediate drop in [ATP] mit levels and also, though less pronounced, in cytosolic ATP.
Our results indicate that a drop in [ATP] mit is prevented through [Ca 2ϩ ] i -stimulated import of nucleotides from the cytosol to the mitochondria across SCaMC-3. This mitochondrial carrier transports both ATP-Mg 2Ϫ and monoprotonated ADP (HADP 2Ϫ ), the affinity for ATP-Mg 2Ϫ is greater than for HADP 2Ϫ (Fiermonte et al., 2004) , and brain ATP levels are several fold higher than those of ADP (Hattori et al., 2010) . On the other hand, NMDA and glutamate induce a rapid drop in the ATP/ADP ratio in cultured neurons ( Fig. 2H-J ; Tantama et al., 2013) , indicating that ADP levels increase upon NMDAdependent ATP breakdown, making it also a likely candidate to be transported under these conditions. To explore this possibility, we used a cytosolic Mg 2ϩ probe, magfura, which has been used as an indicator of cytosolic ATP levels (Abramov and Duchen, 2010) . NMDA addition in the presence of Ca 2ϩ resulted in an increase in cytosolic Mg 2ϩ concentration, which was lower in KO than in WT neurons (Fig. 3 H, I ). Such an increase has been taken to reflect ATP hydrolysis, which leaves Mg 2ϩ unbound (Abramov and Duchen, 2010 . Therefore, we wondered whether the effect of SCaMC-3 on respiration was dependent on a fall in mitochondrial ATP content at the time of stimulation. This possibility was addressed by studying the responses to different doses of NMDA.
Stimulation of respiration by 25 M NMDA was slightly lower than with 50 M NMDA but was sustained, while respiratory stimulation with 50 M NMDA was not (Fig. 4A) . Interestingly, the respiratory response to 25 M NMDA was the same in WT and SCaMC-3 KO neurons (Fig. 4B) with the same evoked [Ca 2ϩ ] i increase (Fig. 4C) . Nevertheless, stimulation of AdN uptake in mitochondria by SCaMC-3 was observed at both high ( Fig. 4A) and low NMDA levels, as the lack of SCaMC-3 resulted in an initial fall in [ATP] mit content in both cases, albeit less pronounced at low NMDA levels (Fig. 4D) . This suggests that SCaMC-3 is activated at both NMDA concentrations. However, respiration was increased only at high NMDA levels, where a fall in [ATP] mit was also revealed in SCaMC-3-deficient neurons. Therefore, the effects of SCaMC-3 on respiration in response to 100 M NMDA are explained by the early [ATP] mit depletion, which allows the effects of the nucleotides entering through SCaMC-3 to increase respiration through mass action ratio on ATP synthesis or ADP allosteric effect on Krebs cycle enzymes (Nichols et al., 1994; Glancy and Balaban, 2012) . We wondered whether the decrease in [ATP] mit , and blunted NMDA-stimulated respiration in SCaMC-3 KO neurons could be associated with an early activation of PARP-1 through the Ca 2ϩ -ROS-PARP-1 pathway. Indeed, NMDAinduced 2-hydroxyethidium formation, which detects superoxide, was very low in the absence of Ca 2ϩ in WT or KO neurons, but greatly increased in the presence of Ca 2ϩ especially in the KO neurons (Fig. 5 A, B) . Moreover, NMDA-induced oxidation of MitoSOX, a mitochondrial superoxide detector (Robinson et al., 2008) , was also higher in SCaMC-3 KO than WT neurons (Fig.  5C,D) . PARP-1 activation by NMDA has been detected as early as 15Ј after NMDA treatment and has been attributed to Ca 2ϩ entry into mitochondria (Duan et al., 2007) . Activation of PARP-1 was found at the earliest time point tested (5 min; Fig. 5E ), but PAR immunoreactivity disappeared at later times, which is consistent with its rapid degradation by poly(ADP-ribose) glycohydrolase (PARG) (Koh et al., 2004) . PARP-1 activation resulted in the accumulation of PAR in cell nuclei and was prevented by PARP-1 inhibitor PJ-34 (Fig. 5F ). However, there was no difference in PAR accumulation between WT and SCaMC-3 KO neurons.
We next tested the effects of PARP-1 activation on the neuronal responses to NMDA. PARP-1 inhibitor 3-AB prevented depletion of cytosolic ATP levels in WT neurons from 200 s onward (Fig. 6A ), in agreement with the known effects of PARP-1 on NAD ϩ and ATP consumption (Alano et al., 2010) . In addition, 3-AB slightly prevented the rapid fall in [ATP] mit in WT neurons (Fig. 6B ), but especially in SCaMC-3 KO neurons (Fig. 6C) . Surprisingly, these different 3-AB concentrations had little effect in NMDA-induced respiratory stimulation in WT neurons but were able to overcome the lack of SCaMC-3 in KO neurons. In these neurons, 3-AB allowed a dose-dependent increase in the initial respiratory responses to NMDA, reaching values identical to those of WT neurons (Fig. 6D-F ) . Preincubation with 5-20 M PJ34 and 20 M DPQ increased NMDA-induced respiratory stimulation both in WT and SCaMC-3 KO neurons, but the increase was clearly larger in the KO neurons (Fig. 6G) . Furthermore, both inhibitors partially prevented the fall in [ATP] mit levels in SCaMC-3 KO neurons (Fig. 6H) . These results indicate that NMDA-induced activation of PARP-1 causes a drastic fall in mitochondrial ATP, which is rescued by AdN uptake in mitochondria through SCaMC-3.
Earlier Ca
2؉ deregulation, lower Ca 2؉ retention capacity, and enhanced permeability transition pore opening probability in SCaMC-3 KO neurons and isolated SCaMC-3 KO mitochondria We have next studied whether the early effects of mitochondrial AdN transport through SCaMC-3 had implications in glutamateinduced delayed Ca 2ϩ deregulation (DCD). In cortical and cerebellar granule neurons, glutamate-induced transient increase in cytosolic Ca 2ϩ is followed by a delayed irreversible rise in cytosolic Ca 2ϩ named delayed calcium deregulation, or DCD (Tymianski et al., 1993) . DCD occurs at the time of a collapse in the mitochondrial membrane potential (Abramov and Duchen, 2008; Duchen, 2012) opening. However, protection against excitotoxic neuronal death by cyclophilin D (CypD) deficiency, a signature of the PTP, is observed only under restricted conditions .
In response to glutamate, SCaMC-3 KO neurons also have a reduced stimulation of respiration and a larger mitochondrial Ca 2ϩ peak, as observed for NMDA (results not shown). The initial [Ca 2ϩ ] i response to 100 M glutamate in cultured neurons from WT (top) and SCaMC-3 KO (bottom) mice was the same (Fig. 7A) , as shown before for NMDA (Fig. 2E) . Nevertheless, a clear difference in the response to glutamate among genotypes was observed at later times. Time to DCD  Fig. 7B ) was reduced in SCaMC-3-deficient neurons, while the percentage of cells undergoing DCD at 50 min (Fig. 7C ) was notably higher in SCaMC-3 KO than in wild-type cultures.
The earlier appearance of DCDs in SCaMC-3 KO neurons may be associated with changes in the mitochondrial Ca but not at low (0.2 mM), concentrations of ADP or ATP-Mg (Traba et al., 2012; Amigo et al., 2013) . Ca 2ϩ -induced swelling in WT and SCaMC-3 KO liver or brain mitochondria was identical in the presence of 0.2 mM ADP (Fig. 7D1,E1) or the pore-forming peptide alamethicin (results not shown). In both types of mitochondria, 0.2 mM ADP was partially protective from swelling, possibly by interacting with the adenine nucleotide translocator (ANT) and triggering the "m" conformation of the carrier, as previously shown in liver mitochondria (Bernardi et al., 2006) . On the other hand, in the presence of 1-2 mM ADP or ATP, WT mitochondria, but not KO mitochondria, showed an enhanced capacity to accumulate Ca 2ϩ ) and a drastic decrease in Ca 2ϩ -induced swelling (Fig. 7D2,D3,E2 ). When Mg 2ϩ was omitted from the buffer, ATP lost the capacity to provide additional protection to WT mitochondria, while ADP (which is transported in the Mg 2ϩ -free form; Fiermonte et al., 2004) still provided protection (Fig. 7D4,D5 ).
Cyclosporine A (CsA) inhibited Ca 2ϩ -induced swelling in liver and brain mitochondria in both genotypes (Fig. 7D6,E3) . Accordingly, CsA increased Ca 2ϩ retention capacity and carboxyatractyloside, an inhibitor of the ANT that stimulates PTP opening, strongly reduced Ca 2ϩ retention in both WT and KO mitochondria, but in the presence of 1 mM ATP-Mg the differences between both genotypes were still observed (Fig. 7 F, G) . These effects of nucleotides were not due to a possible action on mitochondrial K-ATP channels (O'Rourke, 2004) , as differences in swelling were still observed when experiments were conducted in a low (5 mM)-K ϩ medium (results not shown). Together, these results show that AdNs regulate PTP opening in brain mitochondria independently of ANT and CypD, via the ATP-Mg/Pi carrier SCaMC-3, and that the enhanced [ATP] mit depletion in SCaMC-3 KO neurons exposed to NMDA causes a decrease in mitochondrial Ca 2ϩ retention capacity in neuronal SCaMC-3 KO mitochondria that contributes to the early appearance of DCDs in these neurons. 
SCaMC-3 deficiency increases vulnerability to glutamate excitotoxicity in vitro and in vivo with no changes in neuronal excitability
Having shown that NMDA causes a decrease in [ATP] mit and earlier appearance of DCDs in SCaMC-3 KO neurons, we tested whether this was associated with enhanced vulnerability to excitotoxicity. Cortical neuronal cultures were exposed to 10 -100 M glutamate during 5 min, and death was evaluated 6 h later. Neuronal death was increased in the absence of SCaMC-3 at all glutamate concentrations (Fig. 8A) . A similar treatment with 100 M NMDA induced a lower level of neuronal death than glutamate (Fig. 8B) , possibly due to the fact that Na ϩ and Ca ϩ concentrations rose to lower levels than those observed for 100 M glutamate (results not shown) and that metabolic consequences of sustained Na ϩ elevations may lead to the failure of ionic homeostasis in dendrites preceding Ca 2ϩ -dependent cellular compromise (Vander Jagt et al., 2009) . Neuronal death was again increased in SCaMC-3 KO neurons. The presence of PARP-1 inhibitors 3-AB or PJ34 during the exposure and the recovery periods did not protect against NMDA-induced death in WT neurons, but overcame the effect of SCaMC-3 deficiency in KO neurons. (Fig. 8B) .
To analyze the increased susceptibility of SCaMC-3-deficient neurons to glutamate/NMDA-induced cell death in an in vivo context, we studied KA-induced seizures by injecting KA intraperitoneally into age-matched SCaMC-3 KO and wild-type mice. Kainate seizures arise from massive neuronal depolarization due to activation of kainate receptors and Na ϩ and Ca 2ϩ influx into the neuron (Cheng and Sun, 1994; Gimenez-Cassina et al., 2012), which promote enhanced metabolic activity (Ben-Ari, 1981; Al- ] cyt , in Fura-2-loaded neurons upon 100 M NMDA exposure in WT (top) or SCaMC-3 KO (bottom) neurons. Individual cell recordings (in gray) and averages (thick black trace) were shown. The results correspond to a representative experiment. B, Time to inflection (tInflect; i.e., time delay to the start of cytosolic Ca 2ϩ rise after the peak), time to DCD (tDCD; i.e., delay to the onset of secondary Ca 2ϩ raise), and the difference between them are shown. The differences for tDCD were 44.83 Ϯ 1.27 versus 35.73 Ϯ 1.51 min for WT and SCaMC-3 KO neurons (n ϭ 43 WT n ϭ 42 KO; p Յ 0.001). C, Quantification of the percentage of cells undergoing DCD at 50 min, 46.9 Ϯ 5.5 versus 80.41 Ϯ 2.0% in WT and SCaMC-3 KO neurons; p Յ 0.001. Cells that did not undergo DCD after 50 min recording were arbitrarily given a tDCD of 50 min. Data are from at least four independent platings. D, Swelling of isolated liver mitochondria from WT (black traces) and SCaMC-3 KO mice (red traces). Swelling was induced after subsequent Ca 2ϩ pulses (arrows, 20 M each) and measured as a decrease in light scattering (as absorbance at 540 nm) in the presence of ADP 0.2 mM (1), ATP-Mg 1 mM (2), ADP-Mg 2 mM (3), ATP 1 mM (4), ADP 2 mM (5), and ATP-Mg Pi in the presence or absence of 5 M CsA (6). E, Swelling of isolated brain mitochondria after subsequent Ca 2ϩ pulses in the presence of ADP 0.2 mM (1) and ATP-Mg 1 mM, and in the presence or absence of CsA 5 M (2, 3) . F, G, CRC was measured in WT (black traces) and SCaMC-3 KO (red traces) isolated liver mitochondria by using the Ca 2ϩ -sensitive probe Calcium-Green 5N (0.1 M) in the extramitochondrial space in the presence of 1 mM ATP-Mg and 5 M CsA (F) or 10 M carboxyatractyloside (CAT) (G). Representative experiments are shown. ##p Յ 0.01 ###p Յ 0.001, two-tailed unpaired Student's t test. bala et al., 1984) , increasing ATP demand. Secondarily, kainateinduced depolarization will release glutamate, which activates all types of glutamate receptors, particularly NMDA receptors, closing a feedforward cycle promoting long-term damage (Rodríguez-Moreno and Sihra, 2004; Fujikawa, 2005; Vincent and Mulle, 2009) . Defects in mitochondrial Ca 2ϩ handling, such as that caused by Letm1 deficiency, result in higher seizure severity after kainic acid administration (Jiang et al., 2013) . The seizure profile of animals from both genotypes during 2 h after KA administration was monitored. Initial scores were the same in WT and SCaMC-3 KO mice. From 15 min onward, mice lacking SCaMC-3 display a worse outcome (Fig. 8C) . SCaMC-3 KO mice showed high score crises (Ͼ4) earlier and in higher numbers than controls (Fig. 8D) , and all parameters calculated to evaluate the appearance and severity of seizures are consistent with an increased susceptibility in SCaMC-3 KO animals.
Increased seizure profile in SCaMC-3 KO neurons may be due to an increased excitability or to the deleterious consequences of massive glutamate release. To test these hypotheses, we studied the electrophysiological properties of SCaMC-3 KO neurons. We analyzed whole-cell current-clamp recordings for passive cell membrane properties (resting membrane potential and input resistance), active membrane properties (action potential threshold and amplitude), and, finally, spiking capacity, which was measured as the number of APs in response to a given input current in WT and SCaMC-3 KO cortical cells cultured in vitro. We detected no differences in passive or active membrane properties in SCaMC-3 KO in vitro cultured neurons when compared with control neurons (Fig. 8 E, F ) . The lack of changes in neuronal excitability is consistent with the lack of variations among genotypes in the initial seizure profile (Fig. 8C) . Although alterations in synaptic efficacy (increased excitatory or decreased inhibitory drive) as a possible basis for differences in seizure threshold cannot be excluded, the increased seizure scores at later times in SCaMC-3 KO mice are most likely due to increased neuronal damage after kainate insult. We failed to observe neuronal death by Fluoro-Jade B staining, probably due to the strong resistance of C57BL/6 mice to kainate-induced neurodegeneration (McCord et al., 2008; Vincent and Mulle, 2009 ). However, and consistent with this hypothesis, we found enhanced astrogliosis measured by GFAP staining in the SCaMC-3 KO hippocampus 7 d after kainate exposure (Fig. 8G,H ) , which is indicative of increased damage.
Together, the results clearly show that SCaMC-3 deficiency increases neuronal vulnerability to excitotoxicity both in vitro and in vivo.
Discussion
Glutamate is the main excitatory neurotransmitter, and its actions in postsynaptic neurons lead to considerable ATP consumption and compensatory ATP production (Jekabsons and Nicholls, 2004; Nicholls, 2008; Duchen, 2012) , which participate in decoding glutamate signals. However, excessive stimulation by glutamate also contributes to neuronal death through a process known as excitotoxicity (Olney and Sharpe, 1969) . Ca 2ϩ overload is thought to play a major role in excitotoxicity (Stout et al., 1998; Qiu et al., 2013) and studies with different animal and cellular models have revealed that ATP depletion in cytosol (Budd and Nicholls, 1996) , PARP-1 activation (Andrabi et al., 2011) , and PTP opening ) take place after persistent Ca 2ϩ entry through NMDA receptors, and are involved in subsequent neuronal death. However, the role of mitochondrial AdN content in this context is unknown. In this study, we have addressed the contribution of the main ATP-Mg/Pi carrier expressed in brain, SCaMC-3, through its capacity to change the mitochondrial AdN pool, in the early neuronal response to NMDA and in protection against excitotoxic neuronal death.
With a variety of experimental approaches, ranging from Ca 2ϩ transport in isolated mitochondria and respirometry in intact neurons to behavioral seizure monitoring in vivo, we provide evidence for the role of SCaMC-3 in the maintenance of mitochondrial ATP levels throughout excitotoxicity in vitro and in vivo. We have found that (1) Ca 2ϩ activation of SCaMC-3 is required immediately after NMDA exposure to maintain mitochondrial ATP and at later times to maintain cytosolic ATP levels; (2) SCaMC-3 KO neurons undergo a rapid fall in mitochondrial ATP in response to glutamate or NMDA, which prevents full upregulation of respiration; (3) PARP-1 inhibitors prevent the early drop in mitochondrial ATP induced by NMDA and overcome the effects of SCaMC-3 deficiency in NMDA-induced activation of respiration; (4) SCaMC-3 KO neurons show earlier DCDs that are possibly related to the decrease in Ca 2ϩ retention capacity of SCaMC-3-deficient mitochondria incubated with AdNs; and (5) SCaMC-3-deficient neurons and mice are more vulnerable to excitotoxicity with higher neuronal death after in vitro exposure to glutamate or NMDA, and an enhanced convulsive phenotype after in vivo kainate treatment. As enhanced seizures are unrelated to changes in neuronal excitability, and are followed by a larger astrogliosis, the results unveil a role of ScaMC-3 in protecting against excitotoxicity.
Along with Ca 2ϩ entry in the cytosol and mitochondria, glutamate/NMDA is known to cause a rapid increase in respiration, which decays later on, before detectable changes in cell death take 4 Figure 8 . SCaMC-3 KO neurons show an increased vulnerability to glutamate excitotoxicity and a higher seizure level after kainate injection. A, Average neuronal death of cortical neurons from WT (white bars) and SCaMC-3 KO (black bars) 6 h after 5 min glutamate exposure evaluated by calcein-propidium iodide staining. Differences for 10 M Glu (10.35 Ϯ 2.7% vs 24.43 Ϯ 1.6% for WT and SCaMC-3 KO neurons; ##p Յ 0.001) and 100 M Glu (16.4 Ϯ 1.59% vs 26.70 Ϯ 1.9% for WT and SCaMC-3 KO neurons; #p ϭ 0.02). The results were obtained from at least three independent platings, averaged independently and compared. B, Neuronal death 6 h after a 5 min 100 M NMDA exposure in the presence or absence of 5 mM 3-AB or 0.4 M PJ34. The differences for 100 M NMDA exposure were 11.7 Ϯ 1.8% versus 18.70 Ϯ 2.2% for WT and SCaMC-3 KO neurons (##p Յ 0.01). Data from a representative experiment are shown. C, D, SCaMC3-KO mice show increased susceptibility to KA-induced seizures. Mice were administered intraperitoneally with KA (25 mg/kg), and seizure appearance and severity were monitored using Racine's scale (see Materials and Methods). C, Seizure profile of wild-type and SCaMC-3 KO mice after KA treatment. Seizure appearance, with the most severe state every 5 min, is plotted against time for 2 h. For the statistical analysis, normality and variance homogeneity of the data were confirmed using Shapiro-Wilk's and Levene's tests, respectively, and a factorial ANOVA was performed using the severity of the crisis as the dependent variable, and time and genotype as independent variables (n ϭ 8 male mice from each genotype; *p Ͻ 0.05). D, Mean values of different parameters of seizure appearance and severity: "latency time" is the time of appearance of the first state 4 crisis after KA administration; "developed crisis" is the number of state 4 and state 5 crises that developed during the experiment; "accumulative score" is the result of arithmetically adding all states recorded; and "mean level" is the mean of those states (#p Ͻ 0.05; ### p Ͻ 0.001, paired two-tailed Student's t test). E, Neuronal excitability and firing patterns of WT (n ϭ 26) and SCaMC-3 KO (n ϭ 28) neurons obtained from patch-clamp recordings from neuronal cultures at 8 -9 DIV. Resting membrane potential, action potential threshold, and amplitude and input resistance are shown. E, Plot of the number of action potentials elicited by increasing input currents obtained from the same cells. Values for wt (white dots) versus SCaMC-3 KO neurons (black dots) are shown. G, Immunohistochemistry of representative hippocampal sections from kainic acid-treated wild-type and SCaMC-3 KO brains using GFAP antibody. H, Fluorescence quantification of GFAP in hippocampal areas represented as the percentage of the hippocampus area occupied by GFAP signal using ImageJ software (see Materials and Methods; n ϭ 7; #p Ͻ 0.01, paired two-tailed Student's t test). Images were taken and processed using identical conditions and settings. Scale bars, 100 m.
place (Jekabsons and Nicholls, 2004; Yadava and Nicholls, 2007; Gleichmann et al., 2009) . This decrease, which results in a fall in maximal uncoupled respiration, or "spare respiratory capacity," reflects mitochondrial dysfunction (Yadava and Nicholls, 2007) . We found that the initial large increase in OCR in response to NMDA was dependent upon the presence of external Ca 2ϩ , not through the effects of Ca 2ϩ in increasing ATP breakdown (i.e., energy demand), but due to the role of Ca 2ϩ in regulating respiration. Ca 2ϩ upregulation of respiration is required to maintain neuronal ATP levels in response to changes in workload (Llorente-Folch et al., 2013) and to maintain ATP levels in synaptic terminals in response to activity changes (Rangaraju et al., 2014) . Now we find that the maintenance of mitochondrial matrix ATP levels in response to NMDA stimulation requires SCaMC-3. Ca 2ϩ signals induced by NMDA activate AdN transport into mitochondria through SCaMC-3, counteracting the NMDAinduced fall in [ATP] mit , and allow the full upregulation of oxidative phosphorylation (OXPHOS). As the SCaMC-3-induced changes in [ATP] mit parallel those of coupled respiration, it is likely that the ATP synthesis mechanism, ATP synthase itself, and/or ANT, the ATP/ADP exchanger, is the ATP-sensitive process that responds to NMDA-and SCaMC-3-dependent changes in matrix ATP. ATP synthase activity, through its low-affinity site for ADP (100 -200 M; Tomashek et al., 2004) and/or sensitivity to the mass action ratio of matrix AdNs, may explain the effect of SCaMC-3 deficiency on coupled respiration.
[ATP] mit is far more sensitive to OXPHOS variations than [ATP] cyt (Kioka et al., 2013) , and the increased coupled respiration in response to NMDA probably accounts for the preservation of cytosolic ATP levels during NMDA exposure and also to lower ROS production, as the inhibition of coupled respiration is associated with a higher ROS production by mitochondria (Clapham et al., 2000; . On the other hand, increases in matrix ADP levels after SCaMC-3-mediated uptake in mitochondria may contribute to the activation of Krebs cycle dehydrogenases, which are sensitive to both matrix Ca 2ϩ and ADP (Nichols et al., 1994; Glancy and Balaban, 2012) , and thus to the full respiratory response.
A surprising finding of this work is the role of a PARP-1-related process in the early fall in [ATP] mit caused by NMDA exposure. It has long been established that PARP-1 (and PARP-2) activation upon NMDA exposure is involved in early mitochondrial depolarization (Abramov and Duchen, 2008; Alano et al., 2010; Duchen, 2012) . PARP activation causes mitochondrial dysfunction either through direct action of PAR polymers on mitochondria (Andrabi et al., 2011; Virág et al., 2013) or indirectly by limiting substrate supply to mitochondria through PARP-1-dependent consumption of cytosolic, but not mitochondrial, NAD ϩ and inhibition of glycolysis (Alano et al., 2010; Duchen, 2012) . Strikingly, we now find that the rapid fall in [ATP] mit caused by NMDA exposure in SCaMC-3-deficient neurons is prevented by PARP-1 inhibitors, particularly 3-AB, with a smaller effect in the case of PJ-34 or DPQ, in accordance with the role of [ATP] mit in OXPHOS stimulation; these inhibitors also upregulate respiration in SCaMC-3 KO neurons. The connection between PARP-1 activation and the fall in [ATP] mit is still unknown. Mitochondrial PARP-1 activity has been detected in brain (Du et al., 2003; Lai et al., 2008) , and the NAD ϩ salvage pathway, which would drain ATP, has also been found in mammalian mitochondria (Yang et al., 2007; but see Pittelli et al., 2010) . On the other hand, it has been proposed that PAR degradation through PARG and free ADP-ribose causes an increase in cytosolic AMP, which blocks ADP/ATP exchange through ANT and could have an impact on matrix ATP levels. Recently, two different groups have reported a direct action of PAR polymers in mitochondria-associated hexokinase 1, leading to substrate supply impairment and resulting in mitochondrial ATP depletion after PARP-1 activation (Andrabi et al., 2014; Fouquerel et al., 2014) . Whether this occurs in neurons in such a short time window is unknown.
The lack of AdN uptake through SCaMC-3 in response to NMDA not only causes a blunted increase in respiration, but also results in an earlier appearance of DCDs. This is probably related to the lower Ca 2ϩ retention capacity of SCaMC-3 KO mitochondria in the presence of millimolar AdNs. The recent findings relating ATP synthase through its c-ring (Bonora et al., 2013) or ATP synthase dimers (Giorgio et al., 2013) as molecular components of the PTP open the possibility that a direct effect of matrix adenine nucleotides on the ATP synthase is involved in these effects.
Paradoxically, reduced [ATP] mit and Ca 2ϩ retention capacity of mitochondria result in higher matrix free Ca 2ϩ levels, as observed in SCaMC-3 KO neurons during the initial response to NMDA (Fig. 2N ) , and in SCaMC-1 deficient cell lines (Traba et al., 2012) . The reasons for this paradox are not well known but may be related to the behavior of isolated mitochondria, which appeared to contract (an increase in light scattering) immediately after Ca 2ϩ uptake in the presence of 1 mM ATP-Mg, while KO mitochondria did not (results not shown). This has been previously observed in mitochondria of 143B and Cos-7 cells, and in brain mitochondria (Chalmers and Nicholls, 2003; Kristián et al., 2006; Traba et al., 2012) and may reflect the formation of Ca 2ϩ -Pi precipitates, which decrease levels of matrix free Ca 2ϩ (de la Fuente et al., 2012) and perhaps direct chelation of Ca 2ϩ by the nucleotides (Haumann et al., 2010) .
The maintenance of [ATP] mit through SCaMC-3 activity antagonizes [ATP] mit depletion caused by PARP-1, allows the preservation of Ca 2ϩ retention capacity in neuronal mitochondria upon exposure to NMDA, and provides protection against NMDA excitotoxicity and kainate-induced seizures. Glutamate excitotoxicity plays a prominent role in delayed neurodegeneration following prolonged seizure activity, and the lack of SCaMC-3 by increasing the vulnerability to glutamate/NMDA excitotoxicity results in increased astrogliosis, indicating that SCaMC-3 effects observed in vitro are also present in vivo. These properties of SCaMC-3 make it a promising target in strategies aimed at increasing resistance to excitotoxicity.
